Pancreatic Cancer: Warning Signs, Risk Factors, and Prevention Strategies Americans Need to Know in 2026
A June 2026 breakthrough drug daraxonrasib nearly doubles pancreatic cancer survival β the first real treatment advance in years. A 40-year pharmacist explains the warning signs most Americans miss, who is at highest risk, and the prevention strategies with genuine evidence.
